BackgroundTissue microarray (TMA) technology revolutionized the investigation of potential biomarkers from paraffin-embedded tissues. However, conventional TMA construction is laborious, time-consuming and imprecise. Next-generation tissue microarrays (ngTMA) combine histological expertise with digital pathology and automated tissue microarraying. The aim of this study was to test the feasibility of ngTMA for the investigation of biomarkers within the tumor microenvironment (tumor center and invasion front) of six tumor types, using CD3, CD8 and CD45RO as an example.MethodsTen cases each of malignant melanoma, lung, breast, gastric, prostate and colorectal cancers were reviewed. The most representative H&E slide was scanned and uploaded onto a digital slide management platform. Slides were viewed and seven TMA annotations of 1 mm in diameter were placed directly onto the digital slide. Different colors were used to identify the exact regions in normal tissue (n = 1), tumor center (n = 2), tumor front (n = 2), and tumor microenvironment at invasion front (n = 2) for subsequent punching. Donor blocks were loaded into an automated tissue microarrayer. Images of the donor block were superimposed with annotated digital slides. Exact annotated regions were punched out of each donor block and transferred into a TMA block. 420 tissue cores created two ngTMA blocks. H&E staining and immunohistochemistry for CD3, CD8 and CD45RO were performed.ResultsAll 60 slides were scanned automatically (total time < 10 hours), uploaded and viewed. Annotation time was 1 hour. The 60 donor blocks were loaded into the tissue microarrayer, simultaneously. Alignment of donor block images and digital slides was possible in less than 2 minutes/case. Automated punching of tissue cores and transfer took 12 seconds/core. Total ngTMA construction time was 1.4 hours. Stains for H&E and CD3, CD8 and CD45RO highlighted the precision with which ngTMA could capture regions of tumor-stroma interaction of each cancer and the T-lymphocytic immune reaction within the tumor microenvironment.ConclusionBased on a manual selection criteria, ngTMA is able to precisely capture histological zones or cell types of interest in a precise and accurate way, aiding the pathological study of the tumor microenvironment. This approach would be advantageous for visualizing proteins, DNA, mRNA and microRNAs in specific cell types using in situ hybridization techniques.
[1]
T. Nielsen,et al.
Tissue microarrays in clinical oncology.
,
2008,
Seminars in radiation oncology.
[2]
G. Sauter,et al.
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies.
,
2004,
International journal of oncology.
[3]
J. Jass,et al.
Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer
,
2008,
Gut.
[4]
U. Studer,et al.
Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
,
2011,
European urology.
[5]
A. Rehemtulla.
Overcoming intratumor heterogeneity of polygenic cancer drug resistance with improved biomarker integration.
,
2012,
Neoplasia.
[6]
O. Kallioniemi,et al.
Tissue microarray technology for high-throughput molecular profiling of cancer.
,
2001,
Human molecular genetics.
[7]
F. Marincola,et al.
Cancer classification using the Immunoscore: a worldwide task force
,
2012,
Journal of Translational Medicine.
[8]
J. Jass,et al.
Node-Negative Colorectal Cancer at High Risk of Distant Metastasis Identified by Combined Analysis of Lymph Node Status, Vascular Invasion, and Raf-1 Kinase Inhibitor Protein Expression
,
2008,
Clinical Cancer Research.